India's recent regulatory action to rein in the prices of coronary stents seems to have left the medical devices segment nursing some bruises. However, there are fears that more of such action may be brewing for industry.
Part of the apprehension appears stoked by recent diktats, including a note by India’s health ministry to the Medical Council of India (MCI), in response to concerns of the National...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?